Stargardt or Macular Dystrophy Disease in Uganda - Eye Stem Cell Center
- Home
- Stargardt or Macular Dystrophy Disease in Uganda
Stargardt or Macular Dystrophy Disease in Uganda: guidance for young people and parents
Stargardt disease and other macular dystrophies usually begin in childhood or the teenage years, when reading, school work and exams matter most. Because they blur central vision while the eye looks normal from outside, they are often mistaken for ordinary short sight at first. This page explains the condition and the support available.
What is happening in the eye
The macula is the small centre of the retina used for reading, writing and recognising faces. In Stargardt disease, usually linked to the ABCA4 gene, waste material builds up under the macula and the cells there gradually stop working.
Side vision is usually kept, so most people can still find their way around.
Signs to watch for
These are the signs families most often describe.
- Glasses do not fix the blurCentral vision stays poor even with a new prescription.
- Trouble reading the boardOr copying from books and phones.
- A grey or dark spot in the centreFaces and words seem to have gaps.
- Glare and slow recoveryVision takes time to return after bright light.
Protecting the eyes and supporting learning
Simple habits and support make a real difference.
UV protection
Quality UV-blocking sunglasses and a hat help under strong equatorial sun.
Vitamin A caution
Ask your doctor before taking vitamin A supplements, since high intake may not be helpful.
Talk to the school
Sitting near the front, large print and extra time make a big difference.
Use technology
Phone zoom, screen readers and high-contrast settings help many students.
Tests, stem cell therapy and consultation
Here is what to expect when you contact our team.
Tests that confirm the diagnosis
Autofluorescence and OCT imaging, electrical tests, and genetic testing that also helps advise brothers and sisters.
Stem cell therapy as an experimental option
Research has focused on supporting or replacing the RPE cells under the macula. Stem cell therapy for this condition is still experimental. It is not an approved standard treatment, and results differ from person to person. We cannot promise any particular outcome.
Parents are welcome
Parents or guardians are welcome at the assessment, and we encourage young people to ask their own questions.
Arranging a consultation from Uganda
Send reports by WhatsApp or email first. India is about two and a half hours ahead, and we can provide a visa support letter. A yellow fever vaccination certificate is normally required, so please check current rules.
Our Medical Experts – Trusted Specialists
Eye Stem Cell Center brings together pioneers in stem cell biotechnology and highly experienced ophthalmologists to provide advanced regenerative eye care with compassion and precision.
Dr. Pallavi
Senior Consultant | Ophthalmologist & Eye Surgeon22+ Years ExperienceDr. Pallavi is renowned for her expertise in cataract and corneal surgeries. With thousands of successful procedures, she combines surgical precision with a patient‑first approach.
Get Consultation
Dr. Robin
Consultant Ophthalmologist & Eye Surgeon | MD, DO16+ Years ExperienceDr. Robin specializes in advanced cataract surgery, refractive procedures, and keratoconus treatment. His clinical excellence ensures patients receive world‑class eye care.
Get Consultation
Dr. Pawan
Associate Professor | Vitreo-Retina Surgeon10+ Years ExperienceDr. Pawan is an expert in retinal disorders, diabetic retinopathy, and advanced retina procedures. His patient‑focused approach ensures precise treatment and long‑term vision care.
Get Consultation
Frequently asked questions
Will my child go completely blind?
Stargardt typically affects central vision while side vision is usually kept. Severity varies between individuals.
Is it inherited?
Usually yes, most often in a recessive pattern, so parents are often carriers without symptoms.
Is stem cell therapy a cure?
No. It is experimental, and any discussion is about possible benefit, not a cure.
